In the five-year agreement, Medtronic will be the exclusive sales agent for Kuros' product in certain U.S. spine geographies.

For not just years but decades, Medtronic (NYSE: MDT) has proven to be a reliable dividend growth stock to own. Let's take a ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Medtronic is picking up steam with recent product launches, and its balance sheet is a fortress. Read more about MDT stock ...

Medtronic PLC closed $12.81 short of its 52-week high ($92.68), which the company reached on October 24th.

Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.

Medtronic offers solid income potential with a 3.5% dividend yield. Read why MDT stock’s forward P/E ratio signals possible ...

First Hawaiian Bank grew its stake in shares of Medtronic plc (NYSE:MDT – Free Report) by 11.5% in the fourth quarter, ...

Bernstein analyst Lee Hambright lowered the firm’s price target on Medtronic (MDT) to $93 from $97 and keeps an Outperform rating on the shares ...

Kuros Biosciences USA's strategic, exclusive sales agency agreement with Medtronic could boost adoption of its MagnetOs bone ...

Piper Sandler analyst Matthew O’Brien reiterated a Hold rating on Medtronic (MDT – Research Report) today. The company’s shares opened today at ...

The Medtronic Harmony transcatheter pulmonary valve system provides a minimally invasive alternative for congenital heart ...